Business Standard

Dr Reddy's to also use govt cold chain infra for Sputnik V distribution

The vaccine would be transported in frozen form by air and road

Sputnik V, Dr Reddy’s Laboratories, DRL, coronavirus, vaccine, covid-19
Premium

DRL will leverage the existing government cold chain infrastructure used in the national immunisation mission as well as its own cold chain capabilities

Sohini Das Mumbai
Hyderabad-based Dr Reddy’s Laboratories (DRL), the Indian partner for Russia’s Sputnik V, will use the government’s vaccination cold chain infrastructure, along with its own cold chain capabilities, for last-mile distribution of the vaccine in India.
 
Further, 60-70 per cent of Sputnik V’s global production is set to take place in India, said DRL.
 
Sputnik V, a vaccine with 91.6 per cent efficacy — the highest among Covid vaccines available in India — requires a temperature range of -18 degrees C to -22 degrees C to remain stable.
 
Deepak Sapra, CEO (API and Phar­maceutical Services), DRL, said they

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in